SZ 343 Pill - white round, 7mm
Pill with imprint SZ 343 is White, Round and has been identified as Ondansetron Hydrochloride (Orally Disintegrating) 8 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Ondansetron is used in the treatment of Nausea/Vomiting; Nausea/Vomiting, Postoperative; Nausea/Vomiting, Chemotherapy Induced; Nausea/Vomiting, Radiation Induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 343


Ondansetron Hydrochloride (Orally Disintegrating)
- Imprint
- SZ 343
- Strength
- 8 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- 5HT3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- Inactive Ingredients
-
aspartame,
calcium stearate,
silicon dioxide,
mannitol,
microcrystalline cellulose,
polacrilin potassium,
sodium starch glycolate type A potato,
magnesium silicate,
strawberry
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00781-5239 (Discontinued) | Sandoz Inc. |
54569-6124 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
More about ondansetron
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (494)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: 5HT3 receptor antagonists
- Breastfeeding
Patient resources
- Ondansetron drug information
- Ondansetron injection
- Ondansetron (Oral, Oromucosal) (Advanced Reading)
- Ondansetron Oral Solution
Other brands
Professional resources
- Ondansetron monograph
- Ondansetron (FDA)
- Ondansetron Injection (FDA)
- Ondansetron ODT (FDA)
- Ondansetron Oral Solution (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.